Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
出版年份 2021 全文链接
标题
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
作者
关键词
-
出版物
Lancet Respiratory Medicine
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-04-19
DOI
10.1016/s2213-2600(21)00097-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Biologics for chronic rhinosinusitis with nasal polyps
- (2020) Claus Bachert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
- (2020) Valerie Hox et al. Clinical and Translational Allergy
- Real‐life assessment of chronic rhinosinusitis patients using mobile technology: the mySinusitisCoach project by EUFOREA
- (2020) Sven F. Seys et al. ALLERGY
- Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
- (2020) Philippe Gevaert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of short-course glucocorticoid application on patients with chronic rhinosinusitis with nasal polyps
- (2020) Zhaofeng Xu et al. World Allergy Organization Journal
- EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management
- (2020) Claus Bachert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Chronic Rhinosinusitis with Nasal Polyps
- (2019) Claire Hopkins NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
- (2019) Claus Bachert et al. LANCET
- Strategies for composite estimands in confirmatory clinical trials: Examples from trials in nasal polyps and steroid reduction
- (2018) Oliver N. Keene PHARMACEUTICAL STATISTICS
- Management strategies for chronic rhinosinusitis: a qualitative study of GP and ENT specialist views of current practice in the UK
- (2018) Jane Vennik et al. BMJ Open
- Biomarkers for severe eosinophilic asthma
- (2017) Steven W. Yancey et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
- (2017) Claus Bachert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Missing data in clinical trials: control-based mean imputation and sensitivity analysis
- (2017) Devan V. Mehrotra et al. PHARMACEUTICAL STATISTICS
- Investigating the minimal clinically important difference for SNOT-22 symptom domains in surgically managed chronic rhinosinusitis
- (2017) Naweed I. Chowdhury et al. International Forum of Allergy & Rhinology
- Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
- (2017) Geoffrey L Chupp et al. Lancet Respiratory Medicine
- Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre
- (2016) J. van der Veen et al. ALLERGY
- The prevalence of olfactory dysfunction in chronic rhinosinusitis
- (2016) Preeti Kohli et al. LARYNGOSCOPE
- Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis
- (2016) Adam S. DeConde et al. LARYNGOSCOPE
- Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies
- (2016) Hector G Ortega et al. Lancet Respiratory Medicine
- Altered Quality of Life and Psychological Health (SCL-90-R) in Patients With Chronic Rhinosinusitis With Nasal Polyps
- (2015) Jae Ho Chung et al. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
- Characterization of the relationship between dose and blood eosinophil response following subcutaneous administration of mepolizumab
- (2015) Isabelle J. Pouliquen et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Can surgeons predict the olfactory outcomes after endoscopic surgery for nasal polyposis?
- (2015) Duc Trung Nguyen et al. LARYNGOSCOPE
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis
- (2011) Philippe Gevaert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Correlations between symptoms, nasal endoscopy, and in-office computed tomography in post-surgical chronic rhinosinusitis patients
- (2011) William R. Ryan et al. LARYNGOSCOPE
- Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma
- (2010) Claus Bachert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now